Family · Pharmaceutical analytical standards
Nimodipine
A dihydropyridine calcium channel blocker patented in 1971 and approved in Germany in 1985; it is used to prevent cerebral vasospasm after a subarachnoid haemorrhage from a ruptured aneurysm. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was developed as a blood pressure medicine but is not used for that: its special feature is a certain preference for the blood vessels of the brain.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
